FDA approves first drug formulated for children with rare brain tumor September 3, 2012 CenterWatch Staff
Arrowhead completes enrollment in phase 1b trial of CALAA-01 in solid tumors August 31, 2012 CenterWatch Staff
Bayer submits NDA for regorafenib for gastrointestinal stromal tumors August 31, 2012 CenterWatch Staff
QED Clinical Services to launch OrphanReach drug development division August 30, 2012 CenterWatch Staff